Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL188381 (GW806742X) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
mixed lineage kinase domain like pseudokinase/Mixed lineage kinase domain-like protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1938217] [GtoPdb: 2106] [UniProtKB: Q8NB16] | ||||||||
GtoPdb | Surface plasmon resonance (SPR) assay. | - | 5.03 | pKd | 9300 | nM | Kd | Proc Natl Acad Sci USA (2014) 111: 15072-7 [PMID:25288762] |
ChEMBL | Binding affinity to MLKL (unknown origin) | B | 5.03 | pKd | 9300 | nM | Kd | J Med Chem (2020) 63: 1490-1510 [PMID:31622096] |
ChEMBL | Binding affinity to full length human MLKL pseudokinase domain by Kinomescan method | B | 6.28 | pKd | 530 | nM | Kd | J Med Chem (2022) 65: 14971-14999 [PMID:36346971] |
ChEMBL | Binding affinity to full length MLKL (unknown origin) expressed in human HEK293 cells assessed as dissociation constant incubated for 30 mins by Competition Binding Assay | B | 6.28 | pKd | 530 | nM | Kd | J Med Chem (2023) 66: 2361-2385 [PMID:36781172] |
ChEMBL | Binding affinity to full length human MLKL assessed as dissociation constant | B | 6.28 | pKd | 530 | nM | Kd | J Med Chem (2023) 66: 2361-2385 [PMID:36781172] |
GtoPdb | Inhibition of TSQ-induced necroptosis in cellular assays. | - | 7 | pIC50 | 100 | nM | IC50 | Proc Natl Acad Sci USA (2014) 111: 15072-7 [PMID:25288762] |
mixed lineage kinase domain like pseudokinase/Mixed lineage kinase domain-like protein in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5465354] [GtoPdb: 2106] [UniProtKB: Q9D2Y4] | ||||||||
ChEMBL | Binding affinity to recombinant mouse MLKL pseudokinase domain (179 to 464 residues) expressed in Sf21 insect cells assessed as dissociation constant by Surface plasmon resonance assay | B | 5.03 | pKd | 9300 | nM | Kd | J Med Chem (2023) 66: 2361-2385 [PMID:36781172] |
receptor interacting serine/threonine kinase 1/Receptor-interacting serine/threonine-protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5464] [GtoPdb: 2189] [UniProtKB: Q13546] | ||||||||
ChEMBL | Binding affinity to RIPK1 (unknown origin) by Kinomescan method | B | 7.19 | pKd | 64 | nM | Kd | J Med Chem (2022) 65: 14971-14999 [PMID:36346971] |
ChEMBL | Binding affinity to RIPK1 (unknown origin) assessed as dissociation constant | B | 7.19 | pKd | 64 | nM | Kd | J Med Chem (2023) 66: 2361-2385 [PMID:36781172] |
receptor interacting serine/threonine kinase 3/Receptor-interacting serine/threonine-protein kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795199] [GtoPdb: 2191] [UniProtKB: Q9Y572] | ||||||||
ChEMBL | Binding affinity to RIPK3 (unknown origin) by Kinomescan method | B | 6.17 | pKd | 680 | nM | Kd | J Med Chem (2022) 65: 14971-14999 [PMID:36346971] |
ChEMBL | Binding affinity to RIPK3 (unknown origin) assessed as dissociation constant | B | 6.17 | pKd | 680 | nM | Kd | J Med Chem (2023) 66: 2361-2385 [PMID:36781172] |
aurora kinase A/Serine/threonine-protein kinase Aurora-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4722] [GtoPdb: 1936] [UniProtKB: O14965] | ||||||||
ChEMBL | Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument | B | 4.9 | pKd | 12461.05 | nM | Kd | K4DD drug target binding kinetics data |
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
ChEMBL | Inhibitory concentration against human VEGFR2 kinase | B | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 3519-3523 [PMID:15990302] |
GtoPdb | - | - | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 3519-23 [PMID:15990302] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]